Proteasome inhibition with bortezomib suppresses growth and induces apoptosis in osteosarcoma

Development and characterization of a conditionally immortalized human fetal osteoblastic cell line

(2010) Steven A. Harris et al.   JOURNAL OF BONE AND MINERAL RESEARCH

State-of-the-art approach in selective curable tumors: bone sarcoma

(2008) S. S. Bielack et al.   ANNALS OF ONCOLOGY

Targeting the ubiquitin-proteasome system for cancer therapy

(2008) Yili Yang et al.   CANCER SCIENCE

Phase I and Pharmacokinetic Study of Bortezomib in Combination with Idarubicin and Cytarabine in Patients with Acute Myelogenous Leukemia

(2008) E. C. Attar et al.   CLINICAL CANCER RESEARCH

Critical Role of Notch Signaling in Osteosarcoma Invasion and Metastasis

(2008) P. Zhang et al.   CLINICAL CANCER RESEARCH

Elevated expression of Runx2 as a key parameter in the etiology of osteosarcoma

(2008) Saminathan S. Nathan et al.   MOLECULAR BIOLOGY REPORTS

Runx2-mediated activation of the Bax gene increases osteosarcoma cell sensitivity to apoptosis

(2008) R A Eliseev et al.   ONCOGENE